Bone, Joint and Spine Infection Symposium
Join us for an engaging two-day symposium hosted by the Jamieson Trauma Institute, in collaboration with Queensland University of Technology and the PRO-IMPLANT Foundation. This event brings together world-leading surgeons, infection control specialists, and scientists to explore innovative strategies for managing infections across the continuum of care.
Hear from international experts in trauma, orthopaedic and spinal infection management, gain insights into cutting-edge research and clinical practices, and network with professionals dedicated to improving patient outcomes.
Save the date and be part of this important conversation!
|
Registration Type |
Early bird fee (until 31st January 2026) |
Regular fee |
|
Medical |
$220.00 |
$260.00 |
|
Nursing, Allied Health, Research Scientists, other |
$160.00 |
$190.00 |
|
Full Time Students |
$80.00 |
$100.00 |
We welcome all medical, nursing, allied health, academics and students across the following specialities: infectious diseases, microbiology, internal medicine, orthopaedics, traumatology, plastics and reconstructive surgery, other surgical specialities, pathology and radiology. We also welcome participants interested in tissue engineering and materials science, organic chemistry, data analytics, health economics and antimicrobial research.
Will there be any social events for participants?
All participants and faculty are invited to join us for drinks and canapes networking session at the conclusion of the Day 1 program. The networking session will be held at the venue, Owen J Wordsworth Room, S Block, QUT Gardens Point.
Is virtual attendance available?
This symposium will be held exclusively as an in-person event for delegates. All faculty, invited speakers, and sponsors will be present onsite, creating a unique environment for meaningful collaboration and networking that extends well beyond the sessions themselves.
Is the symposium catered?
Yes, morning tea, lunch and afternoon tea are all included in your registration.
Where to stay?
All hotel bookings must be arranged by participants themselves. We are unable to offer discounted accommodation rates for participants, but we suggest choosing accommodation nearby the venue. Please see the below recommendation.
Royal on the Park
152 Alice Street, Brisbane City, QLD 4000
royalonthepark.com.au
+61 7322 13411 | stay@royalonthepark.com.au
About LifeHealthcare:
LifeHealthcare, an EBOS MedTech company, is one of Australia and New Zealand’s leading independent medical technology distributors. Our strength lies in offering the scale of our clinical suppliers with the support of local experts in both countries, ensuring that we understand and meet our local healthcare systems’ unique needs.
LifeHealthcare is focused on providing access to world-leading medical devices and technology for Australian and New Zealand patients whilst ensuring long-term economic sustainability for our healthcare system. LifeHealthcare has a broad portfolio of products in various channels including Spine, Orthopaedics (Recon, Extremities and Regen), Enabling Technology, Robotics, Plastics & Reconstructive Surgery, Neurovascular Intervention, Abdo-Pelvic and Neurosurgery, OR capital and scope repair, to name a few.
Our passion is health. Our purpose is helping to make life better for others.
About DePuy Synthes:
DePuy Synthes, provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, and sports medicine, in addition to the VELYS™ Digital Surgery portfolio, are designed to advance patient care while delivering clinical and economic value to health care systems worldwide.
Building on our proud product innovation and legacy of industry firsts, we are reimagining the orthopaedic landscape with new advancements in medical technologies and digital surgery across the entire continuum of care to Keep People Moving today and tomorrow. For more information, visit www.jnjmedicaldevices.com/en-au/companies/depuy-synthes.
About Medacta:
Medacta is a dynamic, solid, and fast-growing global key player specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgery. Founded in 1999 in Switzerland by a patient, Medacta is committed to responsibly improving the care and well-being of patients while creating value for healthcare systems. Through close collaboration with expert surgeons globally, continuous investments in R&D, and the adoption of cutting-edge technologies, Medacta’s sustainable innovation prioritizes minimally invasive surgery and personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 70 countries.
About Bonalive:
Bonalive is a smart biomaterials company, transforming healthcare at the intersection of biology and technology. With over 30 years of clinical history, and one of the most evidence-based technologies in the industry, we are re-imagining a smarter future for healthcare. Bonalive is a medical device class II certified company.
About Novus Surgical:
Novus Surgical is an Australian medical device company dedicated to elevating the standard of surgical care. We are the exclusive provider of XPERIENCE® Advanced Surgical Irrigation, a biotechnology designed for use in the operating theatre to support patient outcomes.
Since 2022, Novus has supplied over 16,000 units to more than 80 public and private hospitals nationwide. The technology is utilised in procedures including Total Hip and Knee Arthroplasty (THA/TKA), shoulder surgery, and trauma fracture management.
We are driven by clinical efficacy. Across this extensive patient volume to date, our state-based teams have received no reports of post-surgical infections related to the use of our products. Founded by Gary Mitchell, Novus combines over 25 years of industry leadership with a commitment to improving outcomes for Australian patients.
Always read the label and follow the directions for use.
About Stryker:
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
About AKVA Surgical:
AKVA Surgical offers unique and niche orthopaedic surgical solutions, while strictly adhering to orthopaedic codes of conduct. A systematic approach to service allows our team to work with healthcare professionals ensuring the needs of our customers are delivered accurately and on time.
We are always innovative in relation to products and services, with a passion for problem solving. We have the courage and desire to communicate ideas and concepts to improve operation and practices. We strive to be our best and pursue it with dedication and conviction.
Our approach to excellent service stems from a desire to further orthopaedic education within Australia. Our team is committed to in-servicing hospitals to help staff understand the application of our product range and their indications for use. The AKVA team does not make the complex issues of orthopaedic surgery simple, we make them understandable to healthcare professionals at all levels.
About Heraeus Medical:
Heraeus Medical is a specialist orthopaedic company within the Heraeus Group, focused on products used in bone and joint surgery where long-term fixation and infection management are critical considerations. With a heritage in bone cement innovation spanning more than six decades, Heraeus Medical is best known for the PALACOS® and COPAL® portfolios, which are widely used in primary and revision arthroplasty, trauma, and septic settings. The company works closely with surgeons, researchers, and healthcare institutions to support evidence-based practice, consistent cement handling, and surgical outcomes that enable patients to return to life and mobility.
26-27 February 2026
Time: 8:00am
Venue: Owen J Wordsworth Room, Level 12, S-Block, QUT Gardens Point Campus